WCN25-4525 IGA NEPHROPATHY CLINICOPATHOLOGICAL ASSOCIATION WITH MEST-C SCORING

WCN25-4525 IGA NEPHROPATHY CLINICOPATHOLOGICAL ASSOCIATION WITH MEST-C SCORING

Saved in:

Bibliographic Details
Main Authors:	Meghana Rao C, Santanaraman Ramakrishnan, Rangarajan Dilip, Ramalingam Ramprasad, Elenjickal Nikhil
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924023428
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-4235 CHRONICITY SCORE AND NOT MEST C SCORE IS A BETTER PREDICTOR OF PROGNOSIS IN IGA NEPHROPATHY
by: TULSI MODI, et al.
Published: (2025-02-01)

WCN25-4466 Baseline parameters of IgA Nephropathy Using the Oxford MEST Score: Insights from the I-TANGIBLE Registry
by: Kavita Yadav, et al.
Published: (2025-02-01)

WCN24-743 BLIND SPOT IN THE RADAR OF MEST-C SCORE: TYPE AND SEVERITY OF TUBULOINTERSTITIAL NEPHRITIS IN IGA NEPHROPATHY
by: Aurangzeb Afzal, et al.
Published: (2024-04-01)

Prognostic Utility of the MEST-C Score Combined With Clinical Parameters in Hispanic Patients With IgA Nephropathy
by: Lyzinhawer Alza-Arcila, et al.
Published: (2025-01-01)

WCN24-2410 “ASSOCIATION OF GLOMERULAR SYNDROMES WITH HISTOLOGICAL FINDINGS ACCORDING TO THE MEST-C SCORE OF THE OXFORD CLASSIFICATION IN PATIENTS WITH IgA NEPHROPATHY”
by: NIDIAANAHIMOLINA GONZÁLEZ, et al.
Published: (2024-04-01)

WCN25-4505 A DESCRIPTIVE STUDY ON THE CLINICOPATHOLOGICAL PROFILE AND TREATMENT OUTCOME OF IgA NEPHROPATHY USING THE INTERNATIONAL IgA NEPHROPATHY PREDICTION TOOL
by: Arghya Chakraborty, et al.
Published: (2025-02-01)

Kidney Outcomes with Corticosteroid Treatment in IgA Nephropathy According to the Oxford-MEST-C Classification
by: Bancha Satirapoj, et al.
Published: (2025-03-01)

Systematic Review of the Link Between Oxford MEST-C Classification and Complement Activation in IgA Nephropathy
by: Gabriel Ștefan, et al.
Published: (2024-02-01)

Clinicopathological analysis of IgA nephropathy combined with hyperuricemia
by: CAI Wei-cheng, et al.
Published: (2016-01-01)

WCN25-1435 VISUALIZATION OF THE MESANGIAL-CELL-SURFACE AUTOANTIGENS IN IGA NEPHROPATHY
by: Kazuaki Mori, et al.
Published: (2025-02-01)

WCN24-2062 CLINICOPATHOLOGICAL CHARACTERISTICS AND LONG-TERM PROGNOSIS OF IgA NEPHROPATHY PATIENTS WITH NEPHROTIC SYNDROME
by: xiaoling zhou, et al.
Published: (2024-04-01)

Clinicopathological characteristics and related factors of IgA nephropathy with hyperuricemia
by: Ren Hui-min, et al.
Published: (2021-01-01)

WCN25-1709 Salivary and Urinary Metabolomics Study in IgA Nephropathy Patients
by: Rümeyza Kazancıoğlu, et al.
Published: (2025-02-01)

WCN25-844 FELZARTAMAB FOR IgA NEPHROPATHY: FINAL RESULTS OF THE IGNAZ STUDY
by: Uptal Patel, et al.
Published: (2025-02-01)

WCN25-1449 FAMILIAL IGA NEPHROPATHY: A PERPLEXING CONUNDRUM IN A FAMILY
by: MANJARI BHAT, et al.
Published: (2025-02-01)

WCN25-1092 A STUDY OF CLINICOPATHOLOGICAL SPECTRUM AND OUTCOME OF PRIMARY MEMBRANOUS NEPHROPATHY
by: Muzamil ahmad wani, et al.
Published: (2025-02-01)

Clinicopathologic and prognostic analyses in elderly patients with primary IgA nephropathy
by: LIU Lin-lin, et al.
Published: (2017-01-01)

WCN25-4245 A CASE SERIES OF CONCURRENT IGA NEPHROPATHY AND ANTI- GBM DISEASE
by: Priyangani Lohia, et al.
Published: (2025-02-01)

WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
by: Jonathan Barratt, et al.
Published: (2025-02-01)

WCN25-778 AFFINITY study: 1-year results of atrasentan in IgA nephropathy (IgAN)
by: Jonathan Barratt, et al.
Published: (2025-02-01)

WCN25-2007 Evaluation of treatment strategy in patients with IgA nephropathy with impaired renal function
by: Ryousuke Aoki, et al.
Published: (2025-02-01)

WCN25-1387 DIFFUSE ALVEOLAR HEMORRHAGE AS AN ATYPICAL PRESENTATION FOR IgA NEPHROPATHY: CASE REPORT
by: José Fidel Véliz Escobar, et al.
Published: (2025-02-01)

WCN25-2980 ELECTROLYTE IMBALANCE AS A PRESENTING FEATURE IN IGA NEPHROPATHY: A CASE REPORT
by: Zafirah Zahir, et al.
Published: (2025-02-01)

WCN25-892 RARE CASE OF PRTOEINURIC IGA NEPHROPATHY IN A PATIENT WITH IDIOPATHIC INTRACRANIAL HYPERTENSION
by: Sutanay Bhattacharyya
Published: (2025-02-01)

Clinicopathological analysis on adult IgA nephropathy patients with mild urinary abnormalities
by: LIU Fu-jie, et al.
Published: (2015-01-01)

Correlation between serum homocysteine level and clinicopathological factors of IgA nephropathy
by: Cai Xiao-fan, et al.
Published: (2025-01-01)

Correlation between serum homocysteine level and clinicopathological factors of IgA nephropathy
by: Cai Xiao-fan, et al.
Published: (2025-01-01)

WCN25-1471 IgA Nephropathy with Anti-Neutrophil Cytoplasmic Antibodies in a Middle-Aged Patient
by: Giovanna Yazmin Arteaga Müller, et al.
Published: (2025-02-01)

WCN25-2837 POST RENAL TRANSPLANT IMMUNOGLOBULIN A (IgA) NEPHROPATHY - NEED TO LOOK DEEPER !
by: RASHMI ALGERI, et al.
Published: (2025-02-01)

WCN25-3017 IMMUNOSUPPRESSION COMBINED WITH TONSILLECTOMY IS EFFECTIVE IN CAUCASIAN PATIENTS WITH HIGH-RISK PRIMARY IGA-NEPHROPATHY
by: Vladimir Dobronravov, et al.
Published: (2025-02-01)

WCN24-1863 Towards an IgA Nephropathy Atlas
by: Julio Saez-Rodriguez, et al.
Published: (2024-04-01)

WCN25-482 Mesenchymal Stem Cell might be a rescue therapy in severe IgA nephropathy with CKD
by: Byoung Soo Cho, et al.
Published: (2025-02-01)

WCN24-186 JAK/STAT EXPRESSION IN PATIENTS WITH IGA NEPHROPATHY
by: Mateus Luvizotto, et al.
Published: (2024-04-01)

WCN24-2606 KIDNEY RE-BIOPSY IN ADULTS WITH IGA NEPHROPATHY
by: Leonel Langellotti, et al.
Published: (2024-04-01)

WCN25-4090 The Diagnostic potential of Serum Gd-IgA1 to C3 ratio in IgA nephropathy: A single center prospective study
by: Ravi tej Madipalli, et al.
Published: (2025-02-01)

Clinicopathological features and renal dysfunction risk factors of IgA nephropathy patients presenting with mild proteinuria
by: LIU Jie, et al.
Published: (2018-01-01)

WCN25-2338 POTENTIAL DIAGNOSTIC ROLE OF URINARY EXOSOMAL miRNAS IN IgA NEPHROPATHY: A CLINICAL OBSERVATIONAL STUDY
by: Mythri Shankar, et al.
Published: (2025-02-01)

Clinicopathological features of IgA nephropathy in children and adults assessed by the Oxford classification and glomerular crescent lesion typing
by: Bai Qiu-yu, et al.
Published: (2025-03-01)

WCN24-2478 PODOCYTOPATHY ASSOCIATED WITH IGA NEPHROPATHY: IS IT REALLY A PROGNOSTIC FACTOR?
by: BELENGALLEGOS VAZQUEZ, et al.
Published: (2024-04-01)

WCN25-1884 SPARSENTAN (SPAR) AS FIRST-LINE TREATMENT OF INCIDENT PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS OF THE SPARTAN TRIAL
by: Chee Kay Cheung, et al.
Published: (2025-02-01)